Nonalcoholic fatty liver disease and the ongoing role of liver biopsy evaluation

Elizabeth M. Brunt

Research output: Contribution to journalReview articlepeer-review

42 Scopus citations


Nonalcoholic fatty liver disease (NAFLD) is one of the most common underlying causes of chronically elevated liver tests and liver disease in adults and children worldwide and may be strongly suspected if not diagnosed by ever evolving and available serologic and imaging-based noninvasive tests. However, the definitive diagnosis of the most progressive form of NAFLD, nonalcoholic steatohepatitis, and the identification of fibrosis stage still require liver biopsy evaluation as noninvasive testing has not replaced some of the specifics or the totality of information obtainable from liver biopsy. In this review, both the role and value of a liver biopsy evaluation in NAFLD/ nonalcoholic steatohepatitis are examined from publications related to a selected variety of settings. Details of the most commonly used semiquantitative methods of analysis are discussed, and some useful potential pitfalls for differential diagnostic consideration in liver biopsy interpretation are given. (Hepatology Communications 2017;1:370–378).

Original languageEnglish
Pages (from-to)370-378
Number of pages9
JournalHepatology Communications
Issue number5
StatePublished - 2017


Dive into the research topics of 'Nonalcoholic fatty liver disease and the ongoing role of liver biopsy evaluation'. Together they form a unique fingerprint.

Cite this